Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
AssigneeEvolve Biosystems Inc
InventorSteven FRESE
Life of this patent
Estimating the term…
Loading patent…
AssigneeEvolve Biosystems Inc
InventorSteven FRESE
Estimating the term…
This invention relates generally to methods and compositions to achieve and maintain a desirable in vivo phenotype during fermentation and processing of food products for human or animal consumption. The methods and compositions of this invention require an activator that acts as a metabolic trigger for Mammalian Milk Oligosaccharide (MMO) consumption phenotype without necessarily requiring oligosaccharides (i.e a sugar polymer of 3 or more monosaccharides) within the fermentation medium. Compositions containing a non-oligosaccharide activator (e.g. monomers and dimers, and combinations thereof) may be used in fermentation processes of this invention. Turning on MMO-related genes without the use of oligosaccharides is one method of preparing activated commensal bacteria. Embodiments of this invention relate to a composition and a method for preparing a stable, activated and dormant form of commensal bacteria such as: bifidobacteria, lactobacilli or pediococci; for consumption by animals or humans, who are nursing or otherwise receiving MMOs as part of their diet.
A method of preparing activated commensal bacteria, said method comprising culturing said commensal bacterial sp. in the presence of an activator,
A composition comprising an activator and activated commensal bacteria recovered from culture medium according to any one of the preceding claims.
The method, the culture medium, or the composition of any one of the preceding claims, wherein said activator is selected from the compounds listed in Table 4,
The method, the culture medium, or the composition of any one of the preceding claims, wherein the activator is selected from N-acetyl-glucosamine/galactosamine (NAG), dimeric N-acetyl-glucosamine, dimeric N-acetyl-galactosamine, fucose, sialic acid, lacto-N-biose, N-acetyl-lactosamine, galacto-N-bios, or Fuc-α-1,2-Gal-β.
The method, the culture medium, or the composition of any one of the preceding claims, wherein once activated, commensal bacterial cells express a transport system capable of internalizing one or more oligosaccharides before said oligosaccharide is hydrolyzed and consequently said commensal bacterial cells are further capable of hydrolyzing said internalized oligosaccharide, wherein said oligosaccharide has the structure of an oligosaccharide found in a mammalian milk.
The method of any one of the preceding claims, wherein the activated commensal bacterial cells have a higher binding affinity to mammalian mucosal cells than commensal bacterial cells of the same species cultivated on non-activating monomers or dimers.
The method, the culture medium, or the composition of any one of the preceding claims, wherein the activator is added in an amount from 0.1% to 10% of the culture medium (w/v), preferably from 0.1% to 3%.
The method, the culture medium, or the composition of any one of the preceding claims, wherein the activator is present in an amount sufficient to induce expression of a gene encoding for a sialidase, a fucosidase, or an alpha-N-acetylgalactosaminidase, or genes listed in Table 1 or Table 2 in the bacterial cells.
The method, the culture medium, or the composition of any one of the preceding claims, wherein activation of the commensal bacterial cells comprises upregulating Blon_0881 and Blon_2343 in B. infantis or the functional homologues in other bacterial species, said homologues being expressed during activation of said other bacterial species.
The method, the culture medium, or the composition of any one of the preceding claims, wherein activation is glucosamine-6-phosphate isomerase and carbohydrate ABC transporter membrane protein from B. infantis or functional homologues from other Bifidobacterium, Lactobacillus and Pediococcus.
The method, the culture medium, or the composition of any one of the preceding claims, wherein activation of the commensal bacterial cells comprises upregulating the genes selected from the group consisting of Blon_0042, Blon_R0015, Blon_R0017, Blon_R0021, Blon_R0022, Blon_2177 and combinations thereof, and/or downregulating genes selected from the group consisting of Blon_0518, Blon_0785, Blon_2167, Blon_2168 from B. infantis or the functional gene homologues from other Bifidobacterium, Lactobacillus and Pediococcus and combinations thereof.
The method, the culture medium, or the composition of any one of the preceding claims, wherein the commensal bacterial cells comprise an upregulated Blon_0042 gene from B. infantis or the functional gene homologues from other Bifidobacterium, Lactobacillus, Pediococcus, Bacteroides, or Akkermansia.
The method, the culture medium, or the composition of any one of the preceding claims, wherein the commensal bacterial cells comprise a downregulated Blon_2168 and/or Blon_2177 gene from B. infantis or the functional gene homologues from other Bifidobacterium, Lactobacillus and Pediococcus.
The method, the culture medium, or the composition of any one of the preceding claims, wherein activation of the commensal bacterial cells comprise upregulating genes selected from the group consisting of Blon_0882, Blon_0881, Blon 0880, Blon_0879, Blon_2334, Blon_2335, Blon_2336, Blon_2337, Blon_2338, Blon_2339, Blon_2344, Blon_2346, Blon_2347, and Blon_2331 or their functional homologues in other species.
The method, or the culture medium, or the composition of any one of the preceding claims, wherein the commensal bacteria are Bifidobacterium and the bacterium may be B. longum (subsp. longum, or infantis) B. B. breve, B. bifidum or B. pseudocatenulatum.
The method, or the culture medium, or the composition of any one of the preceding claims, wherein the commensal bacteria are Lactobacillus and the Lactobacillus may be L. rhamnosus, L. reuteri, or L. plantarum.
The method, or the culture medium, or the composition of any one of the preceding claims, wherein the commensal bacteria are Pediococcus and the bacterium may be P. acidilactici or P. pentosaceus.
Dependencies are inferred from the claim text.